Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Cancer Center of Kansas - Chanute · Chanute, Kansas
Answer a few short questions to share with the research team.